Authors


Kirby Eng, RPh

Latest:

Specialty Pharmacy Data Standards in a Rapidly Evolving Value-Based World

Specialty medications also are the fastest growing cost component of total health care costs.


Christina Koutsari, PharmD, PhD

Latest:

Fosfomycin Use

Fosfomycin (Monurol) is an antibiotic that uses a unique mechanism of action to establish its bactericidal activity.



Melissa L. Christopher, PharmD

Latest:

Evaluation of Therapeutic Interchange From Donepezil to Galantamine Extended-Release

Therapeutic interchange from donepezil to galantamine extended-release: a 3-month analysis.


Stephen Lagano, MS, PE

Latest:

Specialty Pharmacy and Health Care Reform

Health care reform and the increasing pipeline of specialty have created a "perfect storm" of significant business and financial impacts to patients, insurers, health care providers, manufacturers, and pharmacies.


Yvonne Mai, PharmD

Latest:

Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan Reexamination

Medicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.


Jennifer Tsan, PharmD Candidate

Latest:

An Externship in Public Health

In recent years, career options for pharmacists have grown beyond the traditional settings of retail drugstores and hospitals.


Christine Kim, PharmD

Latest:

Evaluation of Dual Versus Triple Therapy for Hepatitis C

In this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.


Rick Carlson, JDâ€

Latest:

Findings Related to Assessing Value for Private US Health Plans

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.


John C. White, DPM, MS

Latest:

Predictors of Healthcare Costs After Initiating Dabigatran Versus Warfarin

The study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.


Courtney C. Rerecich, PharmD Candidate

Latest:

Medication Therapy Management and Health Care Reform

The changes that the Affordable Care Act has brought to the practice of pharmacy may not be well known.



Amanda D'Ostroph, PharmD Candidate

Latest:

Tips for Managing Adverse Drug Reactions

Fear of adverse drug events often influences adherence decisions.


Anthony J. Mazzarese, PharmD, MSPBA Candidate

Latest:

High Expectations Accompany Specialty Drug Therapies

Clinical outcomes have different meanings among specialty pharmacy stakeholders.


Debbie Weitzman, President of Pharmaceutical Distribution, Cardinal Health

Latest:

The Importance of Provider Status for Pharmacists

Throughout the pandemic, pharmacists have played a critical role in the COVID-19 response in several ways



Sara Miller, PharmD

Latest:

Real-World Evidence Enters the Discussion for Biosimilar Switching

Dedicated clinical trials in IBD cohorts that scrutinized biosimilar use in real-world clinical practice have direct implications on decision making.


Suzanne Soliman

Latest:

Are You a Pharmacist and a Mom?

Currently, more women practice in pharmacy than men, and it is expected that the number of women practicing will continue to rise.


Tom Harper, MPH, CPhT, FCSHP

Latest:

Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19

The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.



Jim Lightwood, PhD

Latest:

Schizophrenia Costs for Newly Diagnosed Versus Previously Diagnosed Patients

Previously diagnosed schizophrenia patients have lower inpatient and higher drug costs compared with newly diagnosed patients, possibly indicating better control of their disease.


Elena Pavlova-McCalla, MD

Latest:

Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and Diacerein

Empirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.


Andrea Szabados

Latest:

Benralizumab for Severe Eosinophilic Asthma

Benralizumab (Fasenra) is indicated as an add-on therapy for patients with severe eosinophilic asthma.


Jan Harris, MPH, BSDH.

Latest:

Vaccine Vial Disposal Guidelines

The Immunization and Infectious Disease initiative for Healthy People 2020 goal is to “increase immunization rates and reduce preventable infectious diseases.”


Jeffrey Hull, RPh

Latest:

Five Technology Trends: Changing Pharmacy Practice Today and Tomorrow

HIT creates value for pharmacies and opportunities for pharmacists to use their professional skills in innovative ways in today's evolving value-based care systems.


Lindsey B. Amerine, PharmD, MS, BCPS

Latest:

Strategies to Overcome the Readmission Crisis in Health Systems

Health care is in the midst of a transformation in which health care providers are increasingly being paid for value provided rather than per service.


Barbara Rapchak, Founder of eMedonline

Latest:

Smartphones and Social Media: Transforming Health Care

Leverage mobile technology to make the delivery of health care easy, low in cost, and comfortable for the patient.


Adam Remick, PharmD

Latest:

Thiamine and Magnesium in Obesity: A Possible Factor in Disease Prevention and Co-Treatment

A recent systematic review has shed light on increased glucose intake in the modern diet and the effects on mechanisms in the body.